NCT00048581 2011-11-21Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.Bristol-Myers SquibbPhase 3 Completed738 enrolled 84 charts